AS ESTRATÉGIAS MITIGADORAS DO IMPACTO DA RESOLUÇÃO 67/2007 DA AGÊNCIA NACIONAL DE VIGILÂNCIA SANITÁRIA PARA AS FARMÁCIAS COM MANIPULAÇÃO

Abstract

The following research study dealt with the legislation that guides the operations of pharmacies with manipulation: The Resolution RDC 67/ANVISA/MS. The supervision of these establishments is a responsibility of the Ministry of Health through the ANVISA and its regional bodies, which published the technical regulation establishing the good manipulation practices in pharmaceuticals. According to the legislation, the pharmacy becomes responsible for the quality of its drugs manipulations, conservation, storage and distribution of such. The pharmacy is also considered essential to the monitoring and control of the entire process of procuring medicinal ingredients to ensure a high quality end product. Using groups I and III as well as Annexes I, II and III, we focused to demonstrate the impact on satisfying the DRC 67/07 along with its strategies to achieve Quality Assurance on the services provided to the community; as wells as to know the importance of quality management as model of excellence in order to better manage a pharmacy and evaluate if the implementation of the RDC will ensure the quality standard of drugs in the compounding sector. The methodology used in this study was a qualitative, descriptive and semi-quantitative approach, through questionnaires distributed to 33 pharmacies containing 30 questions relevant to SGQ regarding the resolution in question, with the purpose of obtaining a clear picture of how that sector was doing. The research results came to validate the assumptions, demonstrating that the compliance with the standards rules within an attainable time frame, along with a better-qualified pharmacist within the fields of management and quality control, will make the pharmacy safer before it s users.